On an unusually sunny January day in New York City, Arielle Duhaime-Ross experienced a collapse that would fundamentally rewrite her relationship with technology. It was one of her first major crashes as a chronically ill person.
For those living with Long Covid or Postural Orthostatic Tachycardia Syndrome (POTS), a crash is not just a bad afternoon. It is a total systemic failure where the body simply stops cooperating. In these moments, the most vital tool for survival is not a doctor on speed dial or a hospital monitor. It is the consumer-grade fitness tracker strapped to the wrist.
We are witnessing a quiet but profound shift in how we perceive wearable technology. For years, companies like WHOOP and Apple marketed these devices as tools for the elite. They were for the biohackers, the marathon runners, and the people obsessed with optimizing their sleep for maximum productivity. But a new demographic has taken over. This group is not looking for a personal record. They are looking for a way to get through the day without ending up bedridden for a week.
From Step Counting to Survival Strategy
The narrative of the fitness tracker is moving away from the gym and into the clinic. This is not because tech companies intended it, but because the disabled community forced the issue.
For people with POTS, where the simple act of standing up can cause the heart rate to skyrocket, real-time data is a necessity. They have moved past the era of counting steps for a digital badge. Now, they use these sensors to monitor basic daily functioning.
This represents a fundamental change in user intent. While an athlete might use a heart rate monitor to see how hard they can push, a person with a chronic illness uses it to see when they must stop. Using a high-end fitness tracker to manage a chronic illness is a bit like using a racing telemetry system to figure out if an aging sedan can make it to the grocery store without the engine seizing. It is about identifying the limits of a fragile system.
The Data-Driven Defense Against the Crash
The primary weapons in this fight are Heart Rate Variability (HRV) and Resting Heart Rate (RHR). These metrics, once the playground of sports scientists, are now the early warning systems for the chronically ill. By watching for a dip in HRV or an unexplained spike in RHR, users can identify an impending symptom flare before it becomes debilitating.
This practice is often called pacing. It is a meticulous way of budgeting energy with the precision of a forensic accountant.
Duhaime-Ross and many others utilize this data to decide if they have the internal resources to take a shower or if they need to stay in bed. The tracker provides an objective mirror to an invisible illness. When a patient feels like they are dying but a standard blood test comes back normal, the tracker offers the validation of a 140 bpm heart rate while standing still. It turns a subjective struggle into an objective data point.
Filling the Healthcare Void
This movement is essentially a grassroots rebellion against a healthcare system that has failed to keep up with complex, invisible conditions. Traditional medicine is often episodic. You see a doctor for fifteen minutes, they take your vitals, and you go home. But illnesses like Long Covid are constant. They do not happen in the fifteen minutes you are in the exam room.
By wearing a tracker 24/7, patients are collecting the long-form data that the medical establishment currently lacks. They are using this information to advocate for themselves. They walk into appointments with months of heart rate graphs, proving that their symptoms are not just anxiety or deconditioning. It is a way of reclaiming agency in a system that often dismisses the lived experience of the disabled.
I have observed this pattern in the tech industry before. Users often find the most profound use cases for a product long after the marketing team has settled on a different pitch. The wearable industry is currently catching up to the fact that their most loyal customers might not be the ones at the CrossFit box, but the ones trying to manage a chronic autonomic nervous system disorder.
The Reliability Gap
However, we must address the elephant in the room. These are consumer devices, not medical-grade equipment. There is a glaring lack of clinical studies verifying the reliability of these sensors for managing specific diseases like POTS over the long term. We do not have a gold standard for which algorithm or sensor is best for a person with a compromised vascular system.
This creates a precarious situation. Users are essentially performing unregulated medical experiments on themselves.
There is also the risk of data anxiety, where the constant monitoring of one's own physiology creates a feedback loop of stress. When your lifeline is a proprietary algorithm owned by a private corporation, you are at the mercy of their software updates and hardware quirks.
As these devices become critical lifelines for millions, we have to ask who is responsible for their accuracy. Does the burden of validation fall on the tech companies, the healthcare system, or the patients themselves? For now, the patients are the ones leading the way. They are turning their wristbands into the medical monitors the world forgot to give them.
